Krishna Institute of Medical Sciences Ltd (KIMS) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 543308 | NSE: KIMS | Hospital & Healthcare Services | Small Cap

Krishna Inst.Medi Share Price

700.15 -5.95 -0.84%
as on 05-Dec'25 09:52

Krishna Institute of Medical Sciences Ltd (KIMS) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 543308 | NSE: KIMS | Hospital & Healthcare Services | Small Cap

DeciZen - make an informed investing decision on Krishna Inst.Medi

Based on:

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Krishna Institute of Medical Sciences stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
96.66
Market Cap:
28,253.8 Cr.
52-wk low:
474.6
52-wk high:
798

Is Krishna Institute of Medical Sciences Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Krishna Inst.Medi: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Krishna Institute of Medical Sciences Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 14.6%4.8%6.4%3.9%22.7%29.6%31.2%22.6%17%17%-
Value Creation
Index
0.3NANA-0.71.01.61.30.70.30.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 4855366287077909331,1431,1321,2221,3841,497
Sales YoY Gr.-10.5%17.3%12.5%11.8%18.1%22.6%-1%8%13.3%-
Adj EPS 0.7-2.9-3.2-1.23.34.976.35.97.27.3
YoY Gr.--515.9%NANANA49.7%43.4%-9.9%-6.8%21.8%-
BVPS (₹) 7.4-4.8-7.913.516.823.434.440.846.754.257.2
Adj Net
Profit
24.3-72-81.3-43.6121189280253235286292
Cash Flow from Ops. 89.479.794.2109161291284271262294-
Debt/CF from Ops. 2.87.97.11.71.10.40.101.22.4-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 12.4%11.9%6.6%13.3%
Adj EPS 29.7%17%0.8%21.8%
BVPS24.7%26.5%16.3%16.2%
Share Price - - 32.5% 13.8%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
9.7-101.951-28.621.524.724.516.813.514.213.1
Op. Profit
Mgn %
21.610.410.38.126.133.13532.129.930.428.2
Net Profit
Mgn %
5-13.4-12.9-6.215.420.324.522.319.320.719.5
Debt to
Equity
1-5.2-3.30.40.30.1000.20.30.3
Working Cap
Days
86919297886664909912940
Cash Conv.
Cycle
-13-2648-11-6-731418-12

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Krishna Institute of Medical Sciences Ltd

Standalone Consolidated
TTM EPS (₹) 7.3 8.4
TTM Sales (₹ Cr.) 1,497 3,402
BVPS (₹.) 57.2 56.7
Reserves (₹ Cr.) 2,210 2,190
P/BV 12.34 12.44
PE 96.66 84.09
From the Market
52 Week Low / High (₹) 474.55 / 798.00
All Time Low / High (₹) 187.61 / 798.00
Market Cap (₹ Cr.) 28,254
Equity (₹ Cr.) 80
Face Value (₹) 2
Industry PE 90.5

Management X-Ray of Krishna Inst.Medi:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *15.5316.1616.1016.1015.7815.3512.1312.030.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Krishna Inst.Medi - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Krishna Inst.Medi

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales4855366287077909331,1431,1321,2221,384
Operating Expenses 380480564650584625745769857963
Manufacturing Costs1544119820349243281285334380
Material Costs119130152167180201250238251275
Employee Cost 7692115127137147174187220236
Other Costs 31217991542183440595272
Operating Profit 105566557206308398363366421
Operating Profit Margin (%) 21.6%10.4%10.3%8.1%26.1%33.0%34.8%32.1%29.9%30.4%
Other Income 434671027241857
Interest 36798836241895728
Depreciation 34353841434545455858
Exceptional Items 00000000011
Profit Before Tax 38-55-57-13147254371337318403
Tax 141724302566938583100
Profit After Tax 24-72-81-44121189278252235303
PAT Margin (%) 5.0%-13.4%-12.9%-6.2%15.3%20.2%24.3%22.3%19.3%21.9%
Adjusted EPS (₹)0.7-2.9-3.2-1.23.34.97.06.35.97.6
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 261-120-1995046249071,3781,6311,8662,168
Share Capital 70505074747880808080
Reserves 191-170-2494295498301,2981,5511,7862,088
Minority Interest0000000000
Debt18820824116114911840322659
Long Term Debt1731982141521476840257577
Short Term Debt1510279250006581
Trade Payables63747974788581737994
Others Liabilities 134581669119106103106108130268
Total Liabilities 6467437898579571,2141,5691,8122,3973,189

Fixed Assets

Gross Block6575396486807127758278891,0081,155
Accumulated Depreciation1593572113153193235277334382
Net Fixed Assets 498504576567559582592612674773
CWIP 26400281316292530
Investments 182331801782135428261,0621,226
Inventories11151619221626192226
Trade Receivables627696100997387120149187
Cash Equivalents 789839250180402130
Others Assets 485361835871128178177417
Total Assets 6467437898579571,2141,5691,8122,3973,189

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 898094109161291284271262294
PBT 38-55-57-13147254371337318403
Adjustment 69172188177625526254824
Changes in Working Capital -19-26-16-29-125-17-17-18-43
Tax Paid 1-11-22-25-47-43-96-75-85-90
Cash Flow From Investing Activity -39-100-52-99-108-317-375-238-569-627
Capex -33-100-45-46-21-72-69-121-320-306
Net Investments -30-000-21256118-1861
Others -30-7-53-87-33-362-235-230-382
Cash Flow From Financing Activity -6125-42-12-242576-15289339
Net Proceeds from Shares 031088095192000
Net Proceeds from Borrowing 089-29-143-35-102-60-14257365
Interest Paid -34-31-28-21-19-14-4-1-5-43
Dividend Paid 0000000000
Others -26-6316633046-5103617
Net Cash Flow -1050-2280-1518-186

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)9.76N/AN/A-28.6721.4824.6424.3716.7913.4615.02
ROCE (%)14.56N/AN/A3.922.7229.5731.2422.5817.0116.99
Asset Turnover Ratio0.760.770.820.860.870.860.820.670.580.5
PAT to CFO Conversion(x)3.71N/AN/AN/A1.331.541.021.081.110.97
Working Capital Days
Receivable Days36475051463426334044
Inventory Days8999977766
Payable Days186191183167154148121118110115

Krishna Institute of Medical Sciences Ltd Stock News

Krishna Institute of Medical Sciences Ltd FAQs

The current trading price of Krishna Inst.Medi on 05-Dec-2025 09:52 is ₹700.1.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Krishna Inst.Medi stood at ₹28,253.8.
The latest P/E ratio of Krishna Inst.Medi as of 04-Dec-2025 is 96.66.
The latest P/B ratio of Krishna Inst.Medi as of 04-Dec-2025 is 12.34.
The 52-week high of Krishna Inst.Medi is ₹798.0 and the 52-week low is ₹474.6.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Krishna Inst.Medi is ₹1,497 ( Cr.) .

About Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences is one of the largest corporate healthcare groups in AP and Telangana in terms of number of patients treated and treatments offered. It also provides multi-disciplinary integrated healthcare services, with a focus on primary secondary & tertiary care in Tier 2-3 cities and primary, secondary, tertiary and quaternary healthcare in Tier 1 cities. It operates multi-specialty hospitals under the “KIMS Hospitals” brand. It also offers a comprehensive range of healthcare services across specialties and super specialties, including cardiac sciences, oncology, neurosciences, gastric sciences, orthopaedics, organ transplantation, renal sciences and mother & child care.

The company strives to provide quality service to more patients, and it has scope for additional patients and improved occupancy rates. It strategically focuses on the southern India healthcare market where it has a strong understanding of regional nuances, customer culture and the mindset of medical professionals and where there is significant and growing need for quality and affordable healthcare services. Each of its hospitals also has integrated diagnostic services and pharmacies that cater to its patients. Affordability and quality of healthcare services provided by it and its track record of building long-term relationships with medical professionals including its doctors, has enabled growth and helped it build its ‘KIMS Hospitals’ brand. It operates and manages all of its hospitals, which provides it with greater control over its facilities and helps it to better deliver high quality and affordable healthcare services.

Business area of the company

The company offers a comprehensive range of healthcare services including oncology, cardiac sciences, neurosciences, gastric sciences, orthopaedics, renal sciences, organ transplantation, and mother & child care.

Awards and Accreditations

  • 2008: KIMS Secunderabad received its first ISO 9001-2008 certification from AQA International LLC.
  • 2011: KIMS Secunderabad received its first accreditation from NABH.
  • 2015: KIMS Secunderabad was awarded the ‘Healthcare Excellence Award’ by the Indo Global Healthcare Summit and Expo.
  • 2015: KIMS Secunderabad was awarded ‘Nursing Excellence’ award by AHPI.
  • 2015: KIMS Secunderabad was accredited with ISO 9001:2015 certification.
  • 2017: KIMS Secunderabad was awarded by AHPI as a ‘Patient Friendly Hospital’.
  • 2017: KIMS Secunderabad became laureate of the Asia Pacific Society of Infection Control CSSD Center of Excellence Silver Award 2015-2016.
  • 2017: KIMS Secunderabad was awarded ‘Best Hospital of the Year’ in the multispecialty hospital category in Hyderabad and eight other specialities by Times Healthcare Achievers Awards.
  • 2019: 2019 KIMS Secunderabad received certificate of excellence in the category of ‘Best Super-Speciality Hospital in Telangana’ at the National Quality Excellence Awards, 2019 hosted by Praxis Media Institute.
  • 2019: KIMS Secunderabad was awarded ‘Best Hospital to Work For’ from AHPI Global Conclave.
  • 2019: KIMS Secunderabad was accredited by NABL.
  • 2019: KIMS Nellore was issued a certificate of accreditation by NABH for being compliant with NABH pre-accreditation entry level hospital requirements.
  • 2020: KIMS Secunderabad ranked the third best hospital in Hyderabad by The Week magazine.
  • 2020: KIMS Kondapur was accredited with a certificate of assessment for exhibition of its intent and commitment towards ensuring safety and hygiene at workplace by IRClass Systems and Solutions.
  • 2021: The cardiology, emergency and trauma, nephrology and neuroscience departments of KIMS Hyderabad were ranked first in the Hyderabad Multi Speciality category in the Times of India, Hyderabad, All India Critical Care Hospital Ranking Survey, 2021.
  • 2021: The emergency and trauma and nephrology departments of KIMS Hyderabad were ranked second in the South Multi Speciality Category in the Times of India, Hyderabad, All India Critical Care Hospital Ranking Survey, 2021.

Major events and milestones

  • 2000: KIMS Nellore established by BRMH. The business division of BRMH, including the hospital, was transferred to our Company pursuant to the 2012 Scheme.
  • 2004: KIMS Secunderabad established by Company.
  • 2010: Investment by Milestone Private Equity Fund (“MPEF”) in Company.
  • 2014: Acquisition of 57.83% of the equity shareholding of Arunodaya Hospitals.
  • 2015: Investment by India Advantage Fund (IAF) and Emerging India Fund (EIF) and exit of MPEF from our Company pursuant to the share purchase agreement dated June 23, 2014 entered into between, amongst others, IAF, EIF and MPEF.
  • 2017: Acquisition of KIMS Ongole by way of slump sale agreement.
  • 2019: Acquisition of 51% of the equity shareholding of ICIMSPL.
  • 2019: Acquisition of 80% of the equity shareholding of SIMSPL.
  • 2019: Investment by General Atlantic in our Company and exit of IAF and EIF from our Company pursuant to the share purchase agreement dated June 14, 2018 entered into between, amongst others, General Atlantic, IAF and EIF.
  • 2020: Acquisition of 55% of the equity shareholding of KHKPL.
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×